The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women

Bone

Volumn 20, Issue 2, 1997, Pages 151-155

  Bjarnason, Nina Hannover ^a,b   Bjarnason, K ^a   Hassager, C ^a   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b CCBR   (Denmark)

Author keywords

Bone mineral density; Bone turnover; Postmenopause; Tibolone

Indexed keywords

ANABOLIC AGENT; BIOCHEMICAL MARKER; CREATININE; OSTEOCALCIN; TIBOLONE;

AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SPINE;

AGED; ANABOLIC AGENTS; BONE DENSITY; BONE REMODELING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LINEAR MODELS; NORPREGNENES; PROGNOSIS;

EID: 0031081215     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00335-3     Document Type: Article

References (19)

1. 1. Bjarnason, N., Bjarnason, K., Haarbo, J., and Christiansen, C. Tibolone: Prevention of postmenopausal bone loss in elderly women. J Clin Endocrinol Metab 81:2419-2422; 1996.
2. 2. Bonde, M., Qvist, P., Fledelius, C., Riis, B. J., and Christiansen, C. Applications of an enzyme immunoassay for a new marker of bone resorption (Cross-Laps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 80:864-868; 1995.
3. 3. Bonde, M., Qvist, P., Fledelius, C., Riis, B. J., and Christiansen, C. Evaluation of an immunoassay for quantitation of type 1 collagen degradation products in urine. Clin Chem 40/11:2022-2025; 1995.
4. 4. Civitelli, R., Gonelli, S., Zacchei, F., Bigazzi, S., Vattimo, A., Avioli, L. V., and Gennari, C. Bone turnover in postmenopausal osteoporosis. Effect of Calcitonin treatment. J Clin Invest 82:1268-1274; 1988.
5. 5. Consensus Development Conference: Diagnosis, Prophylaxis and treatment of Osteoporosis. Am J Med 94:646-650; 1993.
6. 6. Crona, N., Samsioe, G., Lindberg, U.-B., and Silfverstolpe, G. Treatment of climacteric complaints with ORG OD 14: A comparative study with oestradiol valerate and placebo, Maturitas 9:303-308; 1988.
7. 7. Delmas, P. D. Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone 13:S17-S21; 1992.
8. 8. Gernazzani, A. R., Benedek-Jaszmann, L. J., Hart, D. M., Andolsek, L., Kicovic, P. M., and Tax, L. Org OD 14 and the endometrium. Maturitas 13:243-251; 1991.
9. 9. Han, I. K., Ahn, Y. J., and Min, Y. K. Response of hormone replacement therapy on bone mineral density according to serum levels of osteocalcin. J Bone Miner Res 17:S113; 1992.
10. 10. Hansen, M. A., Hassager, C., Overgaard, K., Marslew, U., Riis, B. J., and Christiansen, C. Dual-energy X-ray absorptiometry: A precise method of measuring bone mineral density in the lumbar spine. J Nucl Med 31:1156-1162; 1990.
11. 11. International Federation of Clinical Chemistry (IFCC): IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase. J Clin Chem Clin Biochem 21:731-748; 1983.
12. 12. Kanis, J. A. Osteoporosis. UK: Blackwell Science: 1994; 76-77, 150-151.
13. 13. Lindsay, R., Hart, D. M., and Krasewski, A. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J 280:1207-1209; 1980.
14. 14. Nielsen, N. M., Recke, Pvd, Hansen, M. A., Overgaard, K., and Christiansen, C. Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers. Calcif Tissue Int 55:8-11; 1994.
15. 15. Pødenphant, J., Larsen, N.-E., and Christiansen, C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chem Acta 142:145; 1984.
16. 16. Riis, B. J., Overgaard, K., and Christiansen, C. Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy. Osteoporosis Int 5:276-280; 1995.
17. 17. Rosetiquist, C., Bonde, M., Fledelius, C., and Qvist, P. A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem 40:1258-1264; 1994.
18. 18. Rosenquist, C., Qvist, P., Bjamason, N., and Christiansen, C. Measurement of a more stable region of Osteocalcin in human serum using two monoclonal antibodies in an enzyme-linked immunosorbent assay (ELISA). Clin Chem 41/10:1439-1445; 1995.
19. 19. Rymer, J., Chapman, M. G., and Fogelman, I. Effect of Tibolone on postmenopausal bone loss. Osteoporosis Int 4:314-319; 1994.